Antidepressant sales surge by 64% in India after Covid

The sale of antidepressants and mood elevators in India increased significantly, growing by 64% to Rs 2,536 crore since 2020, driven by virtual consultations and greater awareness. Key medications like Escitalopram and Clonazepam saw notable increases in sales, reflecting reduced mental health stigma and increased treatment acceptance.

Leave a Reply

Your email address will not be published. Required fields are marked *